Development of an antisense-mediated exon skipping therapeutic strategy to correct a frequent causing mutation in Mucolipidosis II

This work is supported by the project PTDC /BBB-BMD/6301/2014 (SPLICETHER) financed by Fundacao para a Ciencia e a Tecnologia – Portugal.